beta-Adrenergic Blocker [EPC]

beta-Adrenergic Blocker [EPC] was reported 306053 times

These side effects are most commonly reported by patients taking drugs of the beta-Adrenergic Blocker [EPC] class:

# Drug class Count
0 FATIGUE 18398
1 DRUG INEFFECTIVE 16969
2 NAUSEA 16518
3 DYSPNOEA 16455
4 DIARRHOEA 16028
5 DIZZINESS 14619
6 HEADACHE 12015
7 ASTHENIA 11557
8 PAIN 11387
9 OFF LABEL USE 10732
10 HYPOTENSION 10649
11 FALL 10280
12 DEATH 9544
13 VOMITING 9050
14 MALAISE 8867
15 HYPERTENSION 8814
16 ACUTE KIDNEY INJURY 8525
17 ARTHRALGIA 8484
18 PNEUMONIA 8014
19 WEIGHT DECREASED 7988
20 RENAL FAILURE 7552
21 PAIN IN EXTREMITY 7355
22 COUGH 7096
23 ANAEMIA 6768
24 PRURITUS 6686
25 MYOCARDIAL INFARCTION 6643
26 RASH 6588
27 CHEST PAIN 6557
28 BLOOD PRESSURE INCREASED 6470
29 CHRONIC KIDNEY DISEASE 6426
30 CARDIAC FAILURE CONGESTIVE 6359
31 DECREASED APPETITE 6024
32 DRUG INTERACTION 6011
33 ANXIETY 6009
34 BACK PAIN 5976
35 INSOMNIA 5822
36 PYREXIA 5741
37 CONSTIPATION 5553
38 OEDEMA PERIPHERAL 5341
39 ABDOMINAL PAIN 5141
40 ATRIAL FIBRILLATION 5086
41 CONDITION AGGRAVATED 5083
42 DEPRESSION 4994
43 FEELING ABNORMAL 4974
44 URINARY TRACT INFECTION 4916
45 CEREBROVASCULAR ACCIDENT 4844
46 WEIGHT INCREASED 4823
47 GAIT DISTURBANCE 4797
48 DEHYDRATION 4636
49 BLOOD GLUCOSE INCREASED 4619
50 CONFUSIONAL STATE 4551
51 BRADYCARDIA 4549
52 ABDOMINAL PAIN UPPER 4466
53 PERIPHERAL SWELLING 4397
54 SOMNOLENCE 4327
55 MUSCLE SPASMS 4307
56 MYALGIA 4301
57 SYNCOPE 4259
58 CARDIAC FAILURE 4015
59 GASTROINTESTINAL HAEMORRHAGE 3893
60 ALOPECIA 3662
61 ABDOMINAL DISCOMFORT 3601
62 HAEMOGLOBIN DECREASED 3594
63 LOSS OF CONSCIOUSNESS 3483
64 PARAESTHESIA 3387
65 HYPERHIDROSIS 3321
66 ERYTHEMA 3277
67 TOXICITY TO VARIOUS AGENTS 3258
68 PALPITATIONS 3256
69 RENAL IMPAIRMENT 3246
70 HYPOAESTHESIA 3242
71 PRODUCT DOSE OMISSION ISSUE 3225
72 TREMOR 3222
73 MUSCULAR WEAKNESS 3215
74 COMPLETED SUICIDE 3191
75 VISION BLURRED 3072
76 BLOOD CREATININE INCREASED 3064
77 CARDIAC DISORDER 3000
78 BLOOD PRESSURE DECREASED 2981
79 DRUG HYPERSENSITIVITY 2955
80 JOINT SWELLING 2877
81 CONTUSION 2850
82 CARDIAC ARREST 2811
83 DYSPEPSIA 2807
84 FLUSHING 2803
85 MEMORY IMPAIRMENT 2781
86 DIABETES MELLITUS 2738
87 RENAL FAILURE ACUTE 2737
88 NASOPHARYNGITIS 2730
89 HYPERSENSITIVITY 2670
90 SEPSIS 2646
91 GASTROOESOPHAGEAL REFLUX DISEASE 2613
92 CHEST DISCOMFORT 2598
93 HYPERKALAEMIA 2596
94 PRODUCT USE ISSUE 2582
95 DRUG DOSE OMISSION 2576
96 HEART RATE INCREASED 2567
97 EPISTAXIS 2557
98 PRODUCT USE IN UNAPPROVED INDICATION 2555
99 PLATELET COUNT DECREASED 2517
100 INJECTION SITE PAIN 2491
101 HYPONATRAEMIA 2482
102 END STAGE RENAL DISEASE 2458
103 OVERDOSE 2424
104 ABDOMINAL DISTENSION 2418
105 THROMBOCYTOPENIA 2397
106 INCORRECT DOSE ADMINISTERED 2371
107 BALANCE DISORDER 2353
108 CORONARY ARTERY DISEASE 2345
109 DRY MOUTH 2337
110 COVID-19 2294
111 GENERAL PHYSICAL HEALTH DETERIORATION 2260
112 DYSPHAGIA 2210
113 PULMONARY OEDEMA 2209
114 PLEURAL EFFUSION 2200
115 NEUROPATHY PERIPHERAL 2186
116 CHILLS 2182
117 URTICARIA 2179
118 INFECTION 2146
119 RESPIRATORY FAILURE 2112
120 BRONCHITIS 2054
121 INFLUENZA 2036
122 VISUAL IMPAIRMENT 2018
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2016
124 ARTHRITIS 2015
125 HAEMORRHAGE 1998
126 HYPOGLYCAEMIA 1984
127 SINUSITIS 1976
128 SWELLING 1976
129 HEART RATE DECREASED 1969
130 TACHYCARDIA 1963
131 WHITE BLOOD CELL COUNT DECREASED 1951
132 HYPOKALAEMIA 1927
133 RENAL INJURY 1906
134 PULMONARY EMBOLISM 1875
135 FLUID RETENTION 1870
136 RECTAL HAEMORRHAGE 1866
137 ARRHYTHMIA 1859
138 ACUTE MYOCARDIAL INFARCTION 1838
139 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1806
140 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1789
141 EMOTIONAL DISTRESS 1776
142 DRUG INTOLERANCE 1775
143 THROMBOSIS 1768
144 CATARACT 1762
145 PRODUCT QUALITY ISSUE 1749
146 HOSPITALISATION 1748
147 PSORIASIS 1727
148 DYSGEUSIA 1722
149 OEDEMA 1720
150 NEUTROPENIA 1700
151 MUSCULOSKELETAL STIFFNESS 1688
152 HOT FLUSH 1686
153 LETHARGY 1660
154 DISEASE PROGRESSION 1657
155 OROPHARYNGEAL PAIN 1657
156 RHEUMATOID ARTHRITIS 1647
157 INTERNATIONAL NORMALISED RATIO INCREASED 1633
158 UNEVALUABLE EVENT 1598
159 INJURY 1593
160 ANGINA PECTORIS 1592
161 DYSPNOEA EXERTIONAL 1591
162 BLOOD CHOLESTEROL INCREASED 1576
163 MUSCULOSKELETAL PAIN 1572
164 DYSPHONIA 1556
165 STRESS 1545
166 FLATULENCE 1538
167 HAEMATOCHEZIA 1537
168 AMNESIA 1531
169 RHABDOMYOLYSIS 1524
170 DRY SKIN 1523
171 HALLUCINATION 1518
172 BURNING SENSATION 1514
173 OSTEOARTHRITIS 1509
174 VERTIGO 1506
175 FEELING HOT 1471
176 NECK PAIN 1460
177 CELLULITIS 1456
178 ALANINE AMINOTRANSFERASE INCREASED 1443
179 MOBILITY DECREASED 1428
180 DEEP VEIN THROMBOSIS 1411
181 SWELLING FACE 1409
182 ASTHMA 1399
183 RENAL DISORDER 1399
184 RHINORRHOEA 1390
185 OXYGEN SATURATION DECREASED 1386
186 SEIZURE 1376
187 CARDIO-RESPIRATORY ARREST 1374
188 BLOOD GLUCOSE DECREASED 1362
189 TRANSIENT ISCHAEMIC ATTACK 1345
190 GASTROINTESTINAL DISORDER 1342
191 ASPARTATE AMINOTRANSFERASE INCREASED 1304
192 NEPHROGENIC ANAEMIA 1304
193 INTENTIONAL PRODUCT MISUSE 1295
194 ARTHROPATHY 1292
195 MIGRAINE 1287
196 HYPERGLYCAEMIA 1280
197 NERVOUSNESS 1280
198 SLEEP DISORDER 1279
199 MATERNAL EXPOSURE DURING PREGNANCY 1277
200 HEPATIC ENZYME INCREASED 1276
201 ILLNESS 1268
202 BLOOD POTASSIUM DECREASED 1249
203 FOETAL EXPOSURE DURING PREGNANCY 1245
204 TREATMENT NONCOMPLIANCE 1229
205 AGITATION 1223
206 EYE PAIN 1223
207 POLLAKIURIA 1217
208 METABOLIC ACIDOSIS 1216
209 WHEEZING 1214
210 INFUSION RELATED REACTION 1211
211 RASH PRURITIC 1211
212 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1196
213 PANCYTOPENIA 1193
214 TYPE 2 DIABETES MELLITUS 1184
215 HAEMATURIA 1183
216 INTENTIONAL PRODUCT USE ISSUE 1180
217 PANCREATITIS 1175
218 EJECTION FRACTION DECREASED 1160
219 NASAL CONGESTION 1157
220 BONE PAIN 1154
221 MALIGNANT NEOPLASM PROGRESSION 1154
222 SPEECH DISORDER 1146
223 PRODUCTIVE COUGH 1143
224 INFLUENZA LIKE ILLNESS 1140
225 MACULAR DEGENERATION 1136
226 BLOOD PRESSURE FLUCTUATION 1131
227 MEDICATION ERROR 1131
228 DYSURIA 1118
229 SKIN EXFOLIATION 1112
230 BLISTER 1111
231 NEPHROLITHIASIS 1108
232 SEPTIC SHOCK 1089
233 STOMATITIS 1089
234 MENTAL STATUS CHANGES 1076
235 INTENTIONAL OVERDOSE 1072
236 BLOOD UREA INCREASED 1065
237 DISORIENTATION 1065
238 HYPOXIA 1065
239 ADVERSE EVENT 1064
240 RED BLOOD CELL COUNT DECREASED 1063
241 BLOOD POTASSIUM INCREASED 1061
242 ADVERSE DRUG REACTION 1058
243 PRESYNCOPE 1056
244 HEART RATE IRREGULAR 1050
245 SKIN DISCOLOURATION 1047
246 CARDIOMEGALY 1042
247 MITRAL VALVE INCOMPETENCE 1034
248 HERPES ZOSTER 1031
249 DEPRESSED MOOD 1028
250 HAEMATOCRIT DECREASED 1028
251 DYSARTHRIA 1026
252 OSTEOPOROSIS 1023
253 WHITE BLOOD CELL COUNT INCREASED 1019
254 LACTIC ACIDOSIS 1014
255 NO ADVERSE EVENT 1011
256 ANHEDONIA 1006
257 ORTHOSTATIC HYPOTENSION 1005
258 CARDIOMYOPATHY 1004
259 ELECTROCARDIOGRAM QT PROLONGED 1000
260 TINNITUS 995
261 CHOLELITHIASIS 991
262 PRODUCT SUBSTITUTION ISSUE 991
263 DEPRESSED LEVEL OF CONSCIOUSNESS 990
264 THROAT IRRITATION 982
265 LUNG DISORDER 981
266 CEREBRAL HAEMORRHAGE 980
267 CORONARY ARTERY OCCLUSION 979
268 PULMONARY HYPERTENSION 974
269 VENTRICULAR TACHYCARDIA 973
270 UPPER RESPIRATORY TRACT INFECTION 968
271 CONVULSION 967
272 PRODUCT DOSE OMISSION 964
273 SHOCK 955
274 GASTRITIS 951
275 C-REACTIVE PROTEIN INCREASED 946
276 SUICIDAL IDEATION 944
277 UPPER GASTROINTESTINAL HAEMORRHAGE 943
278 MELAENA 942
279 BLOOD PRESSURE SYSTOLIC INCREASED 941
280 PREMATURE BABY 940
281 INJECTION SITE ERYTHEMA 939
282 SINUS BRADYCARDIA 934
283 ANGIOEDEMA 926
284 URINARY INCONTINENCE 925
285 INTERSTITIAL LUNG DISEASE 924
286 LIVER DISORDER 917
287 HAEMATOMA 910
288 THERAPY INTERRUPTED 909
289 HEAD INJURY 907
290 ASCITES 906
291 INFLAMMATION 905
292 COLITIS 903
293 EXPOSURE DURING PREGNANCY 899
294 CARDIOGENIC SHOCK 896
295 COMA 893
296 UNRESPONSIVE TO STIMULI 891
297 GOUT 886
298 DRY EYE 882
299 FEAR 878
300 FEBRILE NEUTROPENIA 870
301 THERAPEUTIC RESPONSE DECREASED 867
302 SKIN ULCER 866
303 HYPOTHYROIDISM 863
304 DISTURBANCE IN ATTENTION 853
305 EYE IRRITATION 849
306 BLOOD CREATINE PHOSPHOKINASE INCREASED 847
307 UNDERDOSE 839
308 SLEEP APNOEA SYNDROME 832
309 ILL-DEFINED DISORDER 830
310 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 830
311 COGNITIVE DISORDER 828
312 DISCOMFORT 825
313 PERICARDIAL EFFUSION 825
314 SURGERY 824
315 HYPOMAGNESAEMIA 823
316 DRUG EFFECT DECREASED 822
317 STAPHYLOCOCCAL INFECTION 820
318 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 818
319 URINARY RETENTION 818
320 HIP FRACTURE 816
321 SUICIDE ATTEMPT 812
322 ECONOMIC PROBLEM 810
323 LIMB DISCOMFORT 810
324 HYPERLIPIDAEMIA 806
325 TUBULOINTERSTITIAL NEPHRITIS 803
326 SWOLLEN TONGUE 802
327 BLOOD SODIUM DECREASED 799
328 DYSSTASIA 796
329 BLOOD PRESSURE ABNORMAL 795
330 HAEMOPTYSIS 794
331 IRRITABILITY 794
332 THERAPY CESSATION 793
333 CONTRAINDICATED PRODUCT ADMINISTERED 785
334 HAEMORRHOIDS 781
335 HYPOACUSIS 779
336 CYSTITIS 775
337 THERAPEUTIC RESPONSE UNEXPECTED 770
338 HAEMATEMESIS 769
339 DIABETES MELLITUS INADEQUATE CONTROL 768
340 GLYCOSYLATED HAEMOGLOBIN INCREASED 764
341 ANAPHYLACTIC REACTION 762
342 ROAD TRAFFIC ACCIDENT 762
343 DIVERTICULITIS 760
344 INJECTION SITE HAEMORRHAGE 760
345 ACUTE RESPIRATORY FAILURE 755
346 RESPIRATORY DISTRESS 739
347 ABASIA 732
348 PALLOR 730
349 LIMB INJURY 729
350 LIVER FUNCTION TEST ABNORMAL 728
351 HEPATIC STEATOSIS 725
352 IMPAIRED HEALING 725
353 HYPERSOMNIA 722
354 DYSKINESIA 717
355 VISUAL ACUITY REDUCED 714
356 FAECES DISCOLOURED 713
357 RASH ERYTHEMATOUS 710
358 GASTRIC DISORDER 709
359 HYPOCALCAEMIA 709
360 FEELING COLD 707
361 HYPERPARATHYROIDISM SECONDARY 706
362 OCULAR HYPERAEMIA 706
363 COAGULOPATHY 700
364 FEMUR FRACTURE 697
365 INJECTION SITE BRUISING 697
366 LEUKOPENIA 697
367 HYPERTENSIVE CRISIS 696
368 WRONG TECHNIQUE IN DRUG USAGE PROCESS 684
369 APHASIA 682
370 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 682
371 MYOCARDIAL ISCHAEMIA 682
372 RENAL FAILURE CHRONIC 682
373 ERECTILE DYSFUNCTION 681
374 BLOOD ALKALINE PHOSPHATASE INCREASED 679
375 BLOOD TRIGLYCERIDES INCREASED 677
376 GAIT INABILITY 673
377 HYPOPHAGIA 672
378 DELIRIUM 669
379 PANCREATITIS ACUTE 667
380 BLINDNESS 665
381 THERAPY NON-RESPONDER 656
382 INTERVERTEBRAL DISC PROTRUSION 654
383 MULTI-ORGAN FAILURE 653
384 DRUG-INDUCED LIVER INJURY 651
385 LIP SWELLING 651
386 RASH MACULAR 650
387 BREAST CANCER 649
388 FREQUENT BOWEL MOVEMENTS 649
389 TRICUSPID VALVE INCOMPETENCE 644
390 ORAL PAIN 634
391 VENTRICULAR EXTRASYSTOLES 633
392 PLASMA CELL MYELOMA 631
393 NIGHT SWEATS 628
394 FULL BLOOD COUNT DECREASED 627
395 GASTRIC ULCER 627
396 EYE SWELLING 626
397 RESPIRATORY ARREST 626
398 CEREBRAL INFARCTION 625
399 ISCHAEMIC STROKE 625
400 NIGHTMARE 625
401 JAUNDICE 621
402 LACRIMATION INCREASED 620
403 MOVEMENT DISORDER 619
404 LOCALISED INFECTION 618
405 INTESTINAL OBSTRUCTION 617
406 AGEUSIA 615
407 AGGRESSION 614
408 BLOOD PRESSURE INADEQUATELY CONTROLLED 614
409 PHARMACEUTICAL PRODUCT COMPLAINT 614
410 FLUID OVERLOAD 610
411 NEOPLASM MALIGNANT 610
412 SKIN DISORDER 609
413 BLOOD URINE PRESENT 608
414 ABNORMAL DREAMS 606
415 BLOOD BILIRUBIN INCREASED 602
416 FUNGAL INFECTION 602
417 PAIN IN JAW 602
418 ARTERIOSCLEROSIS 597
419 PREMATURE DELIVERY 594
420 DEVICE MALFUNCTION 591
421 DISEASE RECURRENCE 591
422 MENTAL DISORDER 591
423 VIRAL INFECTION 590
424 LOWER RESPIRATORY TRACT INFECTION 588
425 SKIN LESION 588
426 PANIC ATTACK 586
427 HIATUS HERNIA 584
428 INJECTION SITE PRURITUS 583
429 LYMPHADENOPATHY 583
430 CHROMATURIA 580
431 EYE DISORDER 580
432 GLOMERULAR FILTRATION RATE DECREASED 580
433 DEAFNESS 579
434 ENCEPHALOPATHY 579
435 LABORATORY TEST ABNORMAL 579
436 PROCEDURAL PAIN 579
437 RIB FRACTURE 575
438 RESTLESSNESS 574
439 TREATMENT FAILURE 574
440 DEMENTIA 572
441 PULMONARY FIBROSIS 569
442 PSORIATIC ARTHROPATHY 568
443 CIRCULATORY COLLAPSE 564
444 LEUKOCYTOSIS 564
445 SUBDURAL HAEMATOMA 561
446 WOUND 556
447 PARAESTHESIA ORAL 554
448 PROTEINURIA 553
449 PRURITUS GENERALISED 551
450 HEPATIC CIRRHOSIS 549
451 RETCHING 548
452 BODY HEIGHT DECREASED 546
453 HEPATIC FAILURE 543
454 PNEUMONIA ASPIRATION 542
455 DRUG WITHDRAWAL SYNDROME 541
456 BONE DISORDER 540
457 FIBROMYALGIA 538
458 HALLUCINATION, VISUAL 538
459 DEVICE ISSUE 535
460 HEPATITIS 533
461 SKIN BURNING SENSATION 533
462 VENTRICULAR FIBRILLATION 533
463 ACTIVITIES OF DAILY LIVING IMPAIRED 532
464 ANGINA UNSTABLE 531
465 NEURALGIA 529
466 DRUG ADMINISTRATION ERROR 528
467 RESPIRATORY DISORDER 528
468 ATRIOVENTRICULAR BLOCK 527
469 ULCER 527
470 EATING DISORDER 525
471 PERIPHERAL COLDNESS 525
472 HAEMORRHAGIC ANAEMIA 524
473 SPINAL OSTEOARTHRITIS 523
474 OBESITY 520
475 COLITIS ULCERATIVE 519
476 JOINT STIFFNESS 519
477 ABNORMAL BEHAVIOUR 515
478 BASAL CELL CARCINOMA 513
479 CARDIOVASCULAR DISORDER 513
480 PULMONARY CONGESTION 513
481 THERAPEUTIC PRODUCT EFFECT DECREASED 513
482 DIALYSIS 511
483 CRYING 508
484 DIPLOPIA 508
485 RESTLESS LEGS SYNDROME 505
486 RASH GENERALISED 504
487 ATELECTASIS 503
488 NOCTURIA 503
489 ECZEMA 500
490 INJECTION SITE SWELLING 499
491 MULTIPLE SCLEROSIS RELAPSE 499
492 RENAL TUBULAR NECROSIS 499
493 LOW BIRTH WEIGHT BABY 497
494 COLD SWEAT 494
495 COORDINATION ABNORMAL 494
496 NEPHROPATHY 493
497 HAIR COLOUR CHANGES 492
498 JOINT INJURY 489
499 PRESCRIBED UNDERDOSE 488
500 WITHDRAWAL SYNDROME 486
501 MUSCULOSKELETAL DISCOMFORT 484
502 DIVERTICULUM 483
503 ATRIAL FLUTTER 482
504 OSTEOMYELITIS 481
505 KIDNEY INFECTION 479
506 ACCIDENTAL OVERDOSE 477
507 POST PROCEDURAL COMPLICATION 477
508 SCIATICA 477
509 SINUS DISORDER 476
510 IRON DEFICIENCY ANAEMIA 473
511 ISCHAEMIC CARDIOMYOPATHY 473
512 DRUG EFFECT INCOMPLETE 469
513 HAIR TEXTURE ABNORMAL 469
514 RENAL CYST 469
515 RESPIRATORY TRACT INFECTION 469
516 GALLBLADDER DISORDER 467
517 LUNG NEOPLASM MALIGNANT 467
518 NEUTROPHIL COUNT DECREASED 467
519 REBOUND ACID HYPERSECRETION 467
520 LOCAL SWELLING 466
521 ORAL CANDIDIASIS 464
522 SPINAL FRACTURE 464
523 DRUG ABUSE 461
524 MIDDLE INSOMNIA 459
525 GAMMA-GLUTAMYLTRANSFERASE INCREASED 458
526 EMOTIONAL DISORDER 457
527 ANOREXIA 456
528 GLAUCOMA 454
529 LEFT VENTRICULAR DYSFUNCTION 454
530 LOWER GASTROINTESTINAL HAEMORRHAGE 454
531 INJECTION SITE REACTION 453
532 CHOKING 451
533 NERVOUS SYSTEM DISORDER 451
534 INTENTIONAL DOSE OMISSION 450
535 MULTIPLE SCLEROSIS 449
536 SYNOVITIS 448
537 LEFT VENTRICULAR HYPERTROPHY 447
538 MUSCULOSKELETAL CHEST PAIN 447
539 THROAT TIGHTNESS 447
540 CLOSTRIDIUM DIFFICILE INFECTION 446
541 CARDIAC MURMUR 445
542 TOOTH DISORDER 445
543 ABDOMINAL PAIN LOWER 444
544 PNEUMONITIS 443
545 ELECTROCARDIOGRAM ABNORMAL 440
546 IRRITABLE BOWEL SYNDROME 440
547 DIZZINESS POSTURAL 438
548 THYROID DISORDER 438
549 HERNIA 437
550 HEPATIC FUNCTION ABNORMAL 436
551 UPPER LIMB FRACTURE 435
552 ACUTE RESPIRATORY DISTRESS SYNDROME 434
553 ARTERIAL OCCLUSIVE DISEASE 434
554 FOOT FRACTURE 434
555 ATRIOVENTRICULAR BLOCK FIRST DEGREE 433
556 PRODUCT PRESCRIBING ERROR 433
557 ACNE 430
558 ERUCTATION 429
559 HEMIPARESIS 429
560 POOR QUALITY SLEEP 429
561 ARTERIOSCLEROSIS CORONARY ARTERY 427
562 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 427
563 CROHN^S DISEASE 425
564 HAEMORRHAGE INTRACRANIAL 423
565 THIRST 423
566 MULTIPLE ORGAN DYSFUNCTION SYNDROME 421
567 OSTEOPENIA 421
568 EYE PRURITUS 417
569 ROTATOR CUFF SYNDROME 417
570 DRUG LEVEL INCREASED 416
571 BACK DISORDER 415
572 PROSTATE CANCER 415
573 ATRIOVENTRICULAR BLOCK COMPLETE 414
574 PULMONARY MASS 414
575 CHOLESTASIS 413
576 MUSCLE TWITCHING 413
577 FEELING JITTERY 412
578 RED BLOOD CELL SEDIMENTATION RATE INCREASED 412
579 BLOOD IRON DECREASED 411
580 ELECTROLYTE IMBALANCE 410
581 HYPERCALCAEMIA 410
582 BUNDLE BRANCH BLOCK LEFT 409
583 DIABETIC NEUROPATHY 409
584 PSYCHOTIC DISORDER 407
585 NEOPLASM PROGRESSION 406
586 MENTAL IMPAIRMENT 405
587 CARDIAC FAILURE CHRONIC 404
588 OESOPHAGITIS 404
589 RASH MACULO-PAPULAR 403
590 BLOOD PRESSURE DIASTOLIC DECREASED 401
591 EYE HAEMORRHAGE 400
592 CARPAL TUNNEL SYNDROME 399
593 SUPRAVENTRICULAR TACHYCARDIA 399
594 IMPAIRED GASTRIC EMPTYING 398
595 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 398
596 BLOOD GLUCOSE ABNORMAL 396
597 AORTIC ANEURYSM 395
598 ANKLE FRACTURE 394
599 CORONARY ARTERY STENOSIS 393
600 HYPOKINESIA 393
601 SKIN CANCER 393
602 GENERALISED OEDEMA 392
603 TASTE DISORDER 392
604 FEEDING DISORDER 391
605 MUCOSAL INFLAMMATION 391
606 TRANSAMINASES INCREASED 391
607 GLOSSODYNIA 390
608 CYANOSIS 389
609 BLOOD MAGNESIUM DECREASED 387
610 CHRONIC SINUSITIS 387
611 SCAR 387
612 TOOTHACHE 387
613 GINGIVAL BLEEDING 386
614 HEAD DISCOMFORT 386
615 HYPOVOLAEMIA 386
616 RALES 386
617 VITAMIN D DEFICIENCY 386
618 EAR INFECTION 385
619 EAR PAIN 385
620 INJECTION SITE MASS 384
621 ACCIDENTAL EXPOSURE TO PRODUCT 383
622 PSYCHOLOGICAL TRAUMA 383
623 INCORRECT DRUG ADMINISTRATION DURATION 382
624 INTERVERTEBRAL DISC DEGENERATION 382
625 SEASONAL ALLERGY 382
626 SNEEZING 382
627 SEDATION 381
628 ANURIA 380
629 PHOTOPHOBIA 380
630 VAGINAL HAEMORRHAGE 380
631 ALTERED STATE OF CONSCIOUSNESS 378
632 SINUS CONGESTION 378
633 URINE OUTPUT DECREASED 377
634 INTERNAL HAEMORRHAGE 374
635 JOINT RANGE OF MOTION DECREASED 373
636 ACUTE CORONARY SYNDROME 372
637 BRASH SYNDROME 372
638 EOSINOPHILIA 372
639 MADAROSIS 371
640 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 371
641 BLOOD COUNT ABNORMAL 369
642 LOWER LIMB FRACTURE 369
643 DRUG DEPENDENCE 368
644 CARDIAC FAILURE ACUTE 367
645 ANGER 366
646 OSTEONECROSIS OF JAW 366
647 GASTROENTERITIS 365
648 HAIR DISORDER 365
649 CORONARY ARTERIAL STENT INSERTION 362
650 AORTIC VALVE INCOMPETENCE 361
651 GASTROENTERITIS VIRAL 361
652 SINUS TACHYCARDIA 361
653 ORTHOPNOEA 360
654 PROSTATIC SPECIFIC ANTIGEN INCREASED 360
655 BACTERIAL INFECTION 359
656 BURSITIS 358
657 BONE DENSITY DECREASED 356
658 EXPIRED PRODUCT ADMINISTERED 353
659 PERIPHERAL VASCULAR DISORDER 353
660 KNEE ARTHROPLASTY 351
661 DRUG PRESCRIBING ERROR 350
662 INCREASED TENDENCY TO BRUISE 350
663 INTENTIONAL DRUG MISUSE 350
664 RESPIRATORY TRACT CONGESTION 349
665 ANAPHYLACTIC SHOCK 348
666 HYPERCHOLESTEROLAEMIA 348
667 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 348
668 MASS 347
669 HAEMODIALYSIS 346
670 HAEMORRHAGIC STROKE 346
671 THINKING ABNORMAL 346
672 DERMATITIS 345
673 ADRENAL INSUFFICIENCY 344
674 BLOOD TEST ABNORMAL 342
675 EXOSTOSIS 342
676 EXTRASYSTOLES 342
677 PRODUCT DOSE OMISSION IN ERROR 342
678 STEVENS-JOHNSON SYNDROME 342
679 CONGESTIVE CARDIOMYOPATHY 341
680 MALNUTRITION 340
681 STENT PLACEMENT 339
682 DECREASED ACTIVITY 338
683 MUSCLE ATROPHY 336
684 AGRANULOCYTOSIS 335
685 MULTIPLE INJURIES 335
686 BREATH SOUNDS ABNORMAL 334
687 EXERCISE TOLERANCE DECREASED 334
688 PERITONITIS 334
689 BLOOD CALCIUM DECREASED 333
690 FLANK PAIN 333
691 MUSCLE TIGHTNESS 332
692 BODY TEMPERATURE INCREASED 331
693 INCREASED APPETITE 331
694 LUNG INFILTRATION 331
695 PHARYNGEAL OEDEMA 331
696 WEIGHT FLUCTUATION 331
697 DRUG ERUPTION 330
698 DYSLIPIDAEMIA 330
699 HYPERTHYROIDISM 330
700 SENSORY DISTURBANCE 326
701 SPLENOMEGALY 326
702 MOOD ALTERED 324
703 BLINDNESS UNILATERAL 323
704 BLOOD GLUCOSE FLUCTUATION 322
705 DIABETIC KETOACIDOSIS 322
706 CLOSTRIDIUM DIFFICILE COLITIS 321
707 HALLUCINATION, AUDITORY 320
708 LARGE INTESTINE POLYP 318
709 PRODUCT AVAILABILITY ISSUE 318
710 CANDIDA INFECTION 316
711 SMALL INTESTINAL OBSTRUCTION 316
712 DISABILITY 314
713 RADICULOPATHY 314
714 SUBARACHNOID HAEMORRHAGE 314
715 TENDERNESS 314
716 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 313
717 HEPATIC ENCEPHALOPATHY 313
718 OSTEONECROSIS 313
719 SPINAL DISORDER 313
720 TEMPERATURE INTOLERANCE 313
721 IMMUNODEFICIENCY 312
722 RASH PAPULAR 311
723 CORONARY ARTERY BYPASS 307
724 SHOCK HAEMORRHAGIC 307
725 CHOLECYSTITIS 306
726 POLYURIA 306
727 MOUTH ULCERATION 305
728 PETECHIAE 305
729 EXTRA DOSE ADMINISTERED 304
730 TROPONIN INCREASED 304
731 DIASTOLIC DYSFUNCTION 303
732 DUODENAL ULCER 303
733 PHOTOSENSITIVITY REACTION 302
734 PROTHROMBIN TIME PROLONGED 302
735 BRONCHOSPASM 301
736 DRUG TOXICITY 300
737 ORAL DISCOMFORT 300
738 TOOTH FRACTURE 300
739 SUDDEN DEATH 299
740 CAROTID ARTERY STENOSIS 298
741 JOINT DISLOCATION 298
742 BLOOD URIC ACID INCREASED 297
743 MICTURITION URGENCY 297
744 SKIN LACERATION 297
745 VENTRICULAR HYPOKINESIA 297
746 SYSTEMIC LUPUS ERYTHEMATOSUS 296
747 HYPOTHERMIA 295
748 CARDIAC VALVE DISEASE 294
749 EMPHYSEMA 293
750 SLUGGISHNESS 293
751 UROSEPSIS 293
752 ECCHYMOSIS 292
753 INITIAL INSOMNIA 292
754 TORSADE DE POINTES 292
755 BACTERAEMIA 290
756 DENTAL CARIES 290
757 LYMPHOCYTE COUNT DECREASED 290
758 PRESCRIBED OVERDOSE 290
759 BREAST CANCER FEMALE 289
760 PARALYSIS 289
761 PRODUCT PHYSICAL ISSUE 289
762 IMPAIRED WORK ABILITY 288
763 HEPATOTOXICITY 287
764 BENIGN PROSTATIC HYPERPLASIA 286
765 DEVICE RELATED INFECTION 286
766 INFARCTION 286
767 TACHYPNOEA 286
768 SKIN IRRITATION 284
769 COLON CANCER 282
770 METASTASES TO BONE 282
771 MOOD SWINGS 282
772 TENDONITIS 282
773 INCONTINENCE 281
774 MUSCULOSKELETAL DISORDER 281
775 POST PROCEDURAL HAEMORRHAGE 280
776 PLATELET COUNT INCREASED 279
777 CARDIAC PACEMAKER INSERTION 278
778 BLOOD ALBUMIN DECREASED 277
779 MYOPATHY 277
780 WRIST FRACTURE 277
781 DECUBITUS ULCER 276
782 PAIN OF SKIN 276
783 QUALITY OF LIFE DECREASED 276
784 METASTASES TO LIVER 275
785 APHONIA 274
786 LUNG INFECTION 274
787 HOSPICE CARE 273
788 PRE-ECLAMPSIA 273
789 BEDRIDDEN 272
790 ESSENTIAL HYPERTENSION 272
791 LACERATION 272
792 POLYP 272
793 SKIN HAEMORRHAGE 272
794 LIVER FUNCTION TEST INCREASED 271
795 THERAPEUTIC RESPONSE SHORTENED 271
796 ACUTE PULMONARY OEDEMA 270
797 POISONING 270
798 PURPURA 270
799 THERAPEUTIC AGENT TOXICITY 270
800 HYPOAESTHESIA ORAL 269
801 SOPOR 268
802 LOW DENSITY LIPOPROTEIN INCREASED 267
803 VITAMIN D DECREASED 267
804 BLADDER DISORDER 266
805 BLOOD LACTATE DEHYDROGENASE INCREASED 266
806 DIVERTICULUM INTESTINAL 266
807 PRODUCT STORAGE ERROR 266
808 MYOCLONUS 265
809 NERVE COMPRESSION 265
810 PULMONARY THROMBOSIS 264
811 TOOTH INFECTION 264
812 TRANSFUSION 263
813 IMPAIRED QUALITY OF LIFE 262
814 PRODUCT ADMINISTRATION ERROR 262
815 VAGINAL DISCHARGE 262
816 EPILEPSY 261
817 NODULE 261
818 PNEUMOTHORAX 261
819 SEROTONIN SYNDROME 261
820 SUSPECTED SUICIDE 261
821 VASCULITIS 261
822 BONE MARROW FAILURE 260
823 PARKINSON^S DISEASE 260
824 RENAL PAIN 260
825 OBSTRUCTIVE AIRWAYS DISORDER 258
826 TOOTH LOSS 256
827 PARANOIA 255
828 ATAXIA 254
829 SPINAL PAIN 254
830 HEPATOMEGALY 253
831 SKIN FISSURES 253
832 HELICOBACTER INFECTION 252
833 INTERNATIONAL NORMALISED RATIO DECREASED 252
834 VITREOUS FLOATERS 252
835 AZOTAEMIA 251
836 GROIN PAIN 251
837 ILEUS 251
838 ASPIRATION 250
839 DELUSION 250
840 EXTRAPYRAMIDAL DISORDER 250
841 LIVER INJURY 250
842 PULMONARY ARTERIAL HYPERTENSION 250
843 BLOOD PRESSURE SYSTOLIC DECREASED 249
844 CARDIAC FLUTTER 249
845 NEEDLE ISSUE 249
846 BODY TEMPERATURE DECREASED 248
847 SQUAMOUS CELL CARCINOMA 248
848 NERVE INJURY 247
849 PULSE ABSENT 247
850 ACIDOSIS 246
851 BUNDLE BRANCH BLOCK RIGHT 246
852 CARDIAC OPERATION 246
853 HAEMODYNAMIC INSTABILITY 246
854 HEPATOCELLULAR INJURY 246
855 HIP ARTHROPLASTY 246
856 FACE OEDEMA 244
857 LIGAMENT SPRAIN 244
858 PHARYNGITIS 244
859 CYST 243
860 APPLICATION SITE PRURITUS 242
861 DERMATITIS ATOPIC 242
862 FOETAL GROWTH RESTRICTION 242
863 GASTRIC HAEMORRHAGE 242
864 MYOSITIS 242
865 POST-TRAUMATIC STRESS DISORDER 241
866 TARDIVE DYSKINESIA 241
867 FOOT DEFORMITY 240
868 GASTRIC ULCER HAEMORRHAGE 240
869 MULTIPLE FRACTURES 240
870 SUPRAVENTRICULAR EXTRASYSTOLES 239
871 SCAB 238
872 MALIGNANT MELANOMA 237
873 MUSCLE STRAIN 237
874 TOXIC EPIDERMAL NECROLYSIS 237
875 BACK INJURY 235
876 MYELODYSPLASTIC SYNDROME 234
877 ABSCESS 233
878 RESPIRATORY DEPRESSION 233
879 HYPOPHOSPHATAEMIA 232
880 IMPAIRED DRIVING ABILITY 232
881 DRY THROAT 231
882 INSURANCE ISSUE 231
883 TENDON RUPTURE 231
884 OLIGURIA 230
885 ORAL HERPES 230
886 PRODUCT ADHESION ISSUE 230
887 TOOTH ABSCESS 230
888 VISUAL DISTURBANCE 230
889 APPLICATION SITE ERYTHEMA 229
890 NO THERAPEUTIC RESPONSE 229
891 LEFT VENTRICULAR FAILURE 228
892 GYNAECOMASTIA 227
893 NEUTROPHIL COUNT INCREASED 227
894 PSYCHOMOTOR HYPERACTIVITY 227
895 SPINAL COMPRESSION FRACTURE 227
896 GENERALISED TONIC-CLONIC SEIZURE 226
897 PRODUCT TASTE ABNORMAL 226
898 UPPER-AIRWAY COUGH SYNDROME 226
899 DISSEMINATED INTRAVASCULAR COAGULATION 225
900 SPINAL COLUMN STENOSIS 225
901 BLOOD CALCIUM INCREASED 223
902 ANAL INCONTINENCE 222
903 CONJUNCTIVITIS 222
904 INJECTION SITE RASH 222
905 BRAIN NATRIURETIC PEPTIDE INCREASED 221
906 FRACTURE 221
907 BREAST PAIN 220
908 PROCTITIS 220
909 ABORTION SPONTANEOUS 219
910 RHINITIS 219
911 AORTIC ARTERIOSCLEROSIS 218
912 AORTIC STENOSIS 218
913 BRAIN FOG 218
914 CONCOMITANT DISEASE AGGRAVATED 218
915 DRUG DISPENSING ERROR 218
916 FEMALE GENITAL TRACT FISTULA 217
917 GASTRITIS EROSIVE 217
918 HAEMORRHOIDAL HAEMORRHAGE 217
919 TOOTH EXTRACTION 217
920 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 216
921 POSTOPERATIVE WOUND INFECTION 216
922 SECRETION DISCHARGE 216
923 PRE-EXISTING CONDITION IMPROVED 215
924 PERITONITIS BACTERIAL 214
925 PYELONEPHRITIS 214
926 GASTROINTESTINAL PAIN 213
927 LIPASE INCREASED 213
928 PEMPHIGOID 213
929 PRODUCT DISPENSING ERROR 212
930 WOUND INFECTION 212
931 CAESAREAN SECTION 211
932 LYMPHOMA 211
933 FAILURE TO THRIVE 210
934 MOUTH HAEMORRHAGE 210
935 CARDIOACTIVE DRUG LEVEL INCREASED 209
936 CHOLECYSTITIS ACUTE 209
937 HEMIPLEGIA 209
938 HYPOVOLAEMIC SHOCK 209
939 MUSCLE DISORDER 209
940 VARICES OESOPHAGEAL 209
941 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 208
942 CONCUSSION 208
943 COVID-19 PNEUMONIA 208
944 EAR DISCOMFORT 208
945 HEART RATE ABNORMAL 208
946 RESPIRATORY RATE INCREASED 208
947 LYMPHOEDEMA 207
948 DEVICE DISLOCATION 206
949 EYE INFECTION 206
950 GLUCOSE TOLERANCE IMPAIRED 206
951 PANCREATIC CARCINOMA 206
952 ACCIDENT 205
953 HYDRONEPHROSIS 204
954 ISCHAEMIA 204
955 URINE ODOUR ABNORMAL 204
956 BLADDER CANCER 203
957 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 203
958 FURUNCLE 202
959 METASTASES TO LUNG 202
960 OVERWEIGHT 202
961 PNEUMONIA BACTERIAL 202
962 SCRATCH 202
963 STOMACH DISCOMFORT 202
964 BLOOD CHLORIDE DECREASED 201
965 CAROTID ARTERY OCCLUSION 201
966 ABNORMAL LOSS OF WEIGHT 200
967 IMMUNE SYSTEM DISORDER 200
968 BLOOD THYROID STIMULATING HORMONE INCREASED 199
969 CHOLECYSTECTOMY 199
970 DRUG EXPOSURE DURING PREGNANCY 199
971 MUSCLE RIGIDITY 199
972 NEPHROPATHY TOXIC 199
973 SCOLIOSIS 199
974 SPINAL OPERATION 199
975 ANOSMIA 198
976 VENTRICULAR DYSFUNCTION 198
977 BLOOD CHOLESTEROL ABNORMAL 197
978 HUNGER 197
979 INJECTION SITE NODULE 196
980 KIDNEY TRANSPLANT REJECTION 196
981 REFUSAL OF TREATMENT BY PATIENT 196
982 APPLICATION SITE PAIN 195
983 GINGIVAL PAIN 195
984 NEPHROGENIC SYSTEMIC FIBROSIS 195
985 POTENTIATING DRUG INTERACTION 195
986 BRAIN OEDEMA 194
987 NEOPLASM 194
988 VENTRICULAR ARRHYTHMIA 194
989 APATHY 193
990 HEPATIC CYTOLYSIS 193
991 HIGH DENSITY LIPOPROTEIN DECREASED 193
992 SQUAMOUS CELL CARCINOMA OF SKIN 193
993 ULCER HAEMORRHAGE 193
994 CEREBRAL HAEMATOMA 192
995 HEPATITIS ACUTE 192
996 PELVIC PAIN 192
997 RENAL CANCER 191
998 HYPERVOLAEMIA 190
999 HYPOALBUMINAEMIA 190